Efficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial.

Pericàs, J MMoreno, AAlmela, MGarcía-de-la-Mària, CMarco, FMuñoz, PPeña, Cde Alarcón, ADel Río, AEworo, ACruceta, AParé, J CMestres, C AMiró, J MFOSIMI Investigators2023-01-252023-01-252018-02-03http://hdl.handle.net/10668/12088enAgedAged, 80 and overAnti-Bacterial AgentsBacteremiaEndocarditisFemaleFosfomycinHumansImipenemMaleMethicillin-Resistant Staphylococcus aureusMicrobial Sensitivity TestsMiddle AgedTreatment OutcomeVancomycinEfficacy and safety of fosfomycin plus imipenem versus vancomycin for complicated bacteraemia and endocarditis due to methicillin-resistant Staphylococcus aureus: a randomized clinical trial.research article29408610open access10.1016/j.cmi.2018.01.0101469-0691http://www.clinicalmicrobiologyandinfection.com/article/S1198743X18300648/pdf